John Cohrssen

Filter By:

Topic

Recent Commentary

Analysis and Commentary

The USDA 'Organic' Label Misleads And Rips Off Consumers

by Henry I. Miller, John Cohrssenvia Forbes
Monday, March 7, 2016

There is a Japanese proverb that goes, “Faith makes even the head of a sardine the object of worship.” That’s the sort of devotion that seems to be driving many Americans to buy overpriced organic products such as food, bed linens, pillows and clothes, sales of which increased 83% between 2007 and 2012.

Analysis and Commentary

Will Zika Virus Be The Big Winner At The Summer Olympics?

by John Cohrssen, Henry I. Millervia Forbes
Wednesday, February 17, 2016

This summer Brazil will host Olympiad XXXI. It could become a vast real-world experiment to test whether, how and to what extent Zika virus infection will be spread globally after the expected half million attendees return to their home countries.

Analysis and Commentary

When Food Labels Mislead

by Henry I. Miller, John Cohrssenvia Washington Times
Sunday, February 14, 2016

The USDA ‘organic’ label is both meaningless and unconstitutional.

Featured

We Can Beat Zika And Malaria--If The FDA Allows

by John Cohrssen, Henry I. Millervia Forbes
Friday, January 29, 2016

Zika virus infection, the scary new disease for which there is no vaccine or treatment, is “spreading explosively” from Africa and Southeast Asia, according to the head of the World Health Organization.

Analysis and Commentary

Stunted Harvest

by John Cohrssen, Henry I. Millervia Cato Institute
Tuesday, January 5, 2016

Regulatory reform for biotechnology is a tough row to hoe.

Analysis and Commentary

To Modulate Drug Prices, We Need Less — Not More — Government Involvement

by Henry I. Miller, John Cohrssenvia National Review
Friday, December 11, 2015

In order to control escalating U.S. drug prices that seem to be disconnected from research, development, and manufacturing costs, an array of politicians, policy experts, and pundits have proposed a spectrum of government interventions of varying intrusiveness.

Featured

Biotech Regulation: Will Government Become The Solution Instead Of The Problem?

by Henry I. Miller, John Cohrssenvia Forbes
Wednesday, September 30, 2015

The advent of molecular genetic engineering techniques in the 1970’s promised potential breakthroughs in a wide range of consumer products–more efficient means for producing pharmaceuticals, improved food plants, safer “biorational” pesticides, cleaner energy from biomass and improved traits for animals.

Featured

Supreme Court Free-Speech Decision Clobbers GMO Food-Labeling Activists

by Henry I. Miller, John Cohrssen, Drew L. Kershenvia Forbes
Wednesday, September 16, 2015

Controversy continues to rage over whether foods from genetically engineered plants should have to be labeled as such. The battle has been fought in the media, in state legislatures, through referendum issues and in federal courts. Most mandatory-labeling proposals have failed, and none is in effect.

Analysis and Commentary

How Many Regulators Does It Take to Kill A Mosquito?

by Henry I. Miller, John Cohrssenvia Forbes
Wednesday, October 8, 2014

A British company’s genetic engineering technology could be the Next Big Thing in the control of mosquito-borne diseases like dengue and chikungunya–if regulators don’t erect unreasonable barriers.

Analysis and Commentary

The Meningitis Outbreak We Weren't Ready For

by Henry I. Miller, John Cohrssenvia Los Angeles Times
Wednesday, July 2, 2014

During the last two years, there have been a couple of outbreaks and sporadic cases of bacterial meningitis that federal health agencies failed to address with sufficient aggressiveness. It could have been much worse, and the experience should serve as a wake-up call

Pages